Press Release / General Publication
JRS Group, J. Rettenmaier&Söhne GmbH+Co.KG, Rosenberg (Germany),
July 5th 2024

JRS Pharma GmbH + Co. KG (Germany) and Sudeep Pharma Pvt. Ltd. (India) have jointly decided to end their Joint Venture and the distribution of COMPREZ^® Grades with immediate effect.

This is a result of a Share Purchase Agreement entered into by the two companies. Sudeep shareholders have committed to buy back all shares in Sudeep Pharma Pvt. Ltd. currently owned by the Joint Venture Partner JRS and thus will regain 100% control of Sudeep Pharma. Completion of the transaction has occurred on July 5th, 2024..
Both Sudeep Pharma and JRS Pharma assure all stakeholders that this transaction will have no impact on current operations or product availability.
JRS Group remains fully committed to its strong presence in the Indian market and plans to expand this further in future. The company will continue to grow and to invest in India by its fully owned affiliate Rettenmaier India Private Limited and by its joint venture company Gujarat Microwax Private Limited, and is poised to explore new growth opportunities and ventures.
About JRS Group: JRS is the world's leading manufacturer and technology leader for industrially usable, fine-structured plant fiber products made from re-growing raw materials - e.g. cellulose fibers, wheat fibers, oat fibers, citrus fibers, vegetable fibers, alginates, wood fibers, corn granules, etc.Within the JRS Group, JRS Pharma serves the pharmaceutical and nutraceutical industries with an extensive portfolio of premium quality excipients. A large number of production sites ensure security of supply and short distances - around the globe. As an independent, owner-managed, global active company (more than 4000 employees at over 90 production and sales locations worldwide) with a long history, JRS stands for reliability for over 145 years now - for our customers and our employees.